Loading...
Found 25 results for Lung Disease
A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
A Randomized Phase Ii/Iii Study of Docetaxel and Ramucirumab with or Without Cemiplimab (Regn2810) for Participants Previously Treated with Platinum-Based Chemotherapy and Immunotherapy for Stage Iv or Recurrent Non-Small Cell Lung Cancer (Lung-Map Non-Matched Sub-Study)
R
Rohan Maniar
This phase II/III Expanded Lung-MAP treatment trial compares the effect of adding cemiplimab to docetaxel and ramucirumab versus docetaxel and ramucirumab alone in treating patients with non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Cemiplimab is a monoclonal antibody …
A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of Tng462 in Combination with Other Agents in Patients with Pancreatic or Non-Small Cell Lung Cancer with Mtap Loss and Ras Mutation
A
Anita Turk, MD
TNG462-C102 is a Phase 1/2, open-label, multicenter study designed to determine the safety, tolerability, PK, PD, and preliminary antineoplastic activity of oral TNG462 in combination with the following agents: RMC-6236, RMC-9805, mFOLFIRINOX, or gemcitabine/nab-paclitaxel. Overall, the study comprises a dose escalation phase and a dose expansion phase.Interested in participating? For …
Comparing Stigma in Lung Cancer to Other Tobacco-Related Cancers: A Study from End Lung Cancer Now
B
Bharathi Muthusamy
This is a descriptive, cross-sectional study, which will involve a one-time survey for patients with lung cancer (any histology), pancreatic adenocarcinoma, renal cell carcinoma, and urothelial carcinoma. Patients in this study will be recruited in a prospective basis during their in-person visit to the outpatient Multi-D Subspecialty Oncology Clinic visits at …
Studying DNA Damage and Repair in Lung Diseases
C
Catherine Sears, MD
We will collect cells from the airways and blood of adult patients undergoing clinical bronchoscopy to study how these cells repair DNA after exposure to airborne pollutants like tobacco smoke. We will grow these airway cells in a lab setting to create a 3D model of the lung's surface and …
MOMENTOUS study (iMpact Of an ecg ai ModEl oN The diagnosis Of pUlmonary hypertenSion)
O
Onyedika Ilonze
The goal of this study is to evaluate the use of an ECG-based AI device that may help predict if participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension (PH). The study seeks to determine whether use of the device increases the rate of new …
Virtual Reality to Decrease Pain, Anxiety and Confusion After Surgery
B
Babar Khan, MD
We propose a a prospective study with participants receiving personalized relaxing nature virtual reality (VR) intervention through a VR headset. Our goal is to test the feasibility, acceptability, tolerability and initial clinical efficacy of virtual reality intervention in reducing pain, anxiety, stress and delirium in patients after non major thoracic …
An Observational Study of Lung Screening in Individuals at High Risk for Lung Cancer Who Do Not Meet the Uspstf Criteria
J
Julian Marin Acevedo
Study purposse: Describe the demographics, risk factors for lung cancer, and baseline Lung Rads score of individuals enrolled in this observational study. Using descriptive statistics, compare the demographics and Lung Rads score of the participants enrolled in this study with those participating in the NLST and NELSON studies. Using descriptive …
A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY)
M
Marc Rovner
The purpose of this study is to compare the effect of tezepelumab with placebo on moderate or severe COPD exacerbations in participants with moderate to very severe COPD. THIS STUDY IS ENROLLING BY INVITATION ONLY
Real-World Effectiveness of Mepolizumab In Treating Chronic Obstructive Pulmonary Disease: A Multi-Country Prospective Study
R
Rajeev Mehta
Evaluate the change in annualized rate of moderate/severe exacerbations in the 12-month period post-mepolizumab initiation compared to the 12-month pre-exposure periodTHIS STUDY IS ENROLLING BY INVITATION ONLY - The study will be identifying and enrolling adult patients ≥40 years of age with newly prescribed mepolizumab as add-on therapy per country-specific …
Sample Collection for Research Studies Related to Pulmonary Disorders and Other Diseases of Interest in Infants (Infant Biobank)
S
Stephanie Adaikalam
The broad scientific objective of the Division of Pediatric Pulmonology, Allergy-Immunology and Sleep Medicine (PPUL) at Riley Hospital for Children is to promote translational research for the improved understanding and advancement in the treatment of health disorders. The ability to successfully investigate the biological basis of diseases, translate basic research …
Please choose between Voice or SMS based delivery of verification code
or